Patents by Inventor Brenton Flatt

Brenton Flatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100105675
    Abstract: A compound according to Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R11, L1 and X are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 13, 2009
    Publication date: April 29, 2010
    Applicant: Exelixis, Inc.
    Inventors: Richard Martin, Brenton Flatt, Jackline Dalgard, Venkataiah Bollu, Ping Huang, Raju Mohan, Edwin Schweiger, Tie Lin Wang
  • Publication number: 20070225377
    Abstract: The present invention is directed to 1?,25-dihydroxyvitamin D3 mimics which modulate the vitamin D receptor (VDR). The invention is further directed to pharmaceutical compositions and methods for the treatment, prevention or amelioration of one or more symptoms of disease or disorder related to the activity of the vitamin D receptor using an effective amount of a compound of formula (I).
    Type: Application
    Filed: October 13, 2004
    Publication date: September 27, 2007
    Applicant: X-Ceptor Therapeutics, Inc.
    Inventors: Brenton Flatt, Richard Martin, Raju Mohan, Brett Murphy
  • Publication number: 20070015746
    Abstract: Compounds, compositions and methods are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder related to the activity of the receptors.
    Type: Application
    Filed: July 23, 2004
    Publication date: January 18, 2007
    Applicant: X-CEPTOR THERAPEUTICS INC.
    Inventors: Richard Martin, Tie-Lin Wang, Brenton Flatt, Xiao-Hui Gu
  • Publication number: 20050054634
    Abstract: Compounds, compositions and methods for modulating the activity of receptors are provided. In particular, compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.
    Type: Application
    Filed: December 2, 2003
    Publication date: March 10, 2005
    Inventors: Brett Busch, Brenton Flatt, Xiao-Hui Gu, Richard Martin, Raju Mohan, Tie-Lin Wang, Jason Wu